nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenhydramine—CYP2B6—Sorafenib—liver cancer	0.171	0.242	CbGbCtD
Diphenhydramine—CYP2C19—Sorafenib—liver cancer	0.108	0.154	CbGbCtD
Diphenhydramine—CYP2B6—Doxorubicin—liver cancer	0.104	0.147	CbGbCtD
Diphenhydramine—CYP1A2—Sorafenib—liver cancer	0.1	0.142	CbGbCtD
Diphenhydramine—CYP2C9—Sorafenib—liver cancer	0.0902	0.128	CbGbCtD
Diphenhydramine—CYP2D6—Sorafenib—liver cancer	0.0824	0.117	CbGbCtD
Diphenhydramine—CYP2D6—Doxorubicin—liver cancer	0.05	0.0709	CbGbCtD
Diphenhydramine—Toremifene—ESR1—liver cancer	0.00128	0.0978	CrCbGaD
Diphenhydramine—Clomifene—ESR1—liver cancer	0.0011	0.0846	CrCbGaD
Diphenhydramine—Toremifene—CYP1A1—liver cancer	0.00102	0.0782	CrCbGaD
Diphenhydramine—Bifonazole—CYP2E1—liver cancer	0.00093	0.0712	CrCbGaD
Diphenhydramine—Clomifene—CYP2E1—liver cancer	0.000894	0.0685	CrCbGaD
Diphenhydramine—Clomifene—CYP1A1—liver cancer	0.000882	0.0676	CrCbGaD
Diphenhydramine—Warfarin—CYP1A1—liver cancer	0.000736	0.0564	CrCbGaD
Diphenhydramine—Carbinoxamine—CYP2E1—liver cancer	0.000736	0.0564	CrCbGaD
Diphenhydramine—Brompheniramine—CYP2E1—liver cancer	0.000637	0.0488	CrCbGaD
Diphenhydramine—Cinnarizine—CYP1A1—liver cancer	0.000583	0.0447	CrCbGaD
Diphenhydramine—Fenoprofen—ALB—liver cancer	0.000536	0.041	CrCbGaD
Diphenhydramine—Tamoxifen—ESR1—liver cancer	0.00051	0.0391	CrCbGaD
Diphenhydramine—Phenprocoumon—ALB—liver cancer	0.000462	0.0354	CrCbGaD
Diphenhydramine—Tamoxifen—CYP2E1—liver cancer	0.000413	0.0317	CrCbGaD
Diphenhydramine—Warfarin—ALB—liver cancer	0.00041	0.0314	CrCbGaD
Diphenhydramine—Tamoxifen—CYP1A1—liver cancer	0.000408	0.0312	CrCbGaD
Diphenhydramine—Orphenadrine—CYP2E1—liver cancer	0.000401	0.0308	CrCbGaD
Diphenhydramine—Imipramine—CYP2E1—liver cancer	0.000321	0.0246	CrCbGaD
Diphenhydramine—Amitriptyline—CYP2E1—liver cancer	0.000319	0.0244	CrCbGaD
Diphenhydramine—Phenytoin—ALB—liver cancer	0.000298	0.0228	CrCbGaD
Diphenhydramine—Amitriptyline—ALB—liver cancer	0.000175	0.0134	CrCbGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PIK3CG—liver cancer	4.21e-05	0.000149	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GSTA1—liver cancer	4.19e-05	0.000149	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—MTHFR—liver cancer	4.15e-05	0.000147	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—CYP1A1—liver cancer	4.15e-05	0.000147	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—NAT2—liver cancer	4.15e-05	0.000147	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—PIK3CD—liver cancer	4.14e-05	0.000147	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—PIK3CD—liver cancer	4.07e-05	0.000145	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PPARA—liver cancer	4.07e-05	0.000145	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—MTHFR—liver cancer	4.03e-05	0.000143	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PIK3CB—liver cancer	4.02e-05	0.000143	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	4e-05	0.000142	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.99e-05	0.000142	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ALDOB—liver cancer	3.98e-05	0.000141	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PPARA—liver cancer	3.95e-05	0.00014	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—HPGDS—liver cancer	3.91e-05	0.000139	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—HPGDS—liver cancer	3.88e-05	0.000138	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—MTHFR—liver cancer	3.87e-05	0.000137	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.86e-05	0.000137	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.85e-05	0.000137	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.8e-05	0.000135	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PRKCE—liver cancer	3.8e-05	0.000135	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PPARA—liver cancer	3.79e-05	0.000135	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CRABP1—liver cancer	3.79e-05	0.000135	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PSMA4—liver cancer	3.79e-05	0.000135	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PSMD10—liver cancer	3.79e-05	0.000135	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GSTP1—liver cancer	3.78e-05	0.000134	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PIK3CD—liver cancer	3.76e-05	0.000133	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PRKCE—liver cancer	3.74e-05	0.000133	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—HMOX1—liver cancer	3.73e-05	0.000132	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PIK3CD—liver cancer	3.7e-05	0.000131	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GOT2—liver cancer	3.69e-05	0.000131	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—PIK3CB—liver cancer	3.61e-05	0.000128	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IGF2—liver cancer	3.6e-05	0.000128	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—PIK3CB—liver cancer	3.55e-05	0.000126	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.55e-05	0.000126	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IGF2—liver cancer	3.54e-05	0.000126	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.51e-05	0.000125	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PSMD10—liver cancer	3.49e-05	0.000124	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PSMA4—liver cancer	3.49e-05	0.000124	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3CG—liver cancer	3.49e-05	0.000124	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GSTM1—liver cancer	3.48e-05	0.000123	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CYP2E1—liver cancer	3.47e-05	0.000123	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.47e-05	0.000123	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PSMA4—liver cancer	3.46e-05	0.000123	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PSMD10—liver cancer	3.46e-05	0.000123	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.41e-05	0.000121	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GOT2—liver cancer	3.39e-05	0.00012	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PIK3CG—liver cancer	3.38e-05	0.00012	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PPARG—liver cancer	3.36e-05	0.000119	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CSF2—liver cancer	3.36e-05	0.000119	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GOT2—liver cancer	3.36e-05	0.000119	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.36e-05	0.000119	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—RAF1—liver cancer	3.36e-05	0.000119	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—H2AFX—liver cancer	3.32e-05	0.000118	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—HPGDS—liver cancer	3.31e-05	0.000118	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—IL2—liver cancer	3.31e-05	0.000118	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CSF2—liver cancer	3.31e-05	0.000117	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—RAF1—liver cancer	3.3e-05	0.000117	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CYP1A1—liver cancer	3.3e-05	0.000117	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.3e-05	0.000117	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PIK3CB—liver cancer	3.28e-05	0.000116	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PPARG—liver cancer	3.27e-05	0.000116	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—H2AFX—liver cancer	3.26e-05	0.000116	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—IL2—liver cancer	3.26e-05	0.000116	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CG—liver cancer	3.25e-05	0.000115	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CYCS—liver cancer	3.24e-05	0.000115	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PIK3CB—liver cancer	3.22e-05	0.000114	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CYP2E1—liver cancer	3.19e-05	0.000113	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GOT1—liver cancer	3.18e-05	0.000113	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GGT1—liver cancer	3.18e-05	0.000113	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CYP2E1—liver cancer	3.16e-05	0.000112	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PPARG—liver cancer	3.14e-05	0.000111	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—MTHFR—liver cancer	3.07e-05	0.000109	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3CD—liver cancer	3.07e-05	0.000109	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.06e-05	0.000109	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—ALB—liver cancer	3.03e-05	0.000107	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PPARA—liver cancer	3.02e-05	0.000107	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—IL2—liver cancer	3.01e-05	0.000107	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3e-05	0.000107	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TERT—liver cancer	3e-05	0.000106	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CYCS—liver cancer	2.98e-05	0.000106	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PIK3CD—liver cancer	2.98e-05	0.000106	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.96e-05	0.000105	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—IL2—liver cancer	2.96e-05	0.000105	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CYCS—liver cancer	2.96e-05	0.000105	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PSMA4—liver cancer	2.95e-05	0.000105	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PSMD10—liver cancer	2.95e-05	0.000105	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TERT—liver cancer	2.95e-05	0.000105	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—ALB—liver cancer	2.94e-05	0.000104	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GGT1—liver cancer	2.93e-05	0.000104	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GOT1—liver cancer	2.93e-05	0.000104	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GOT1—liver cancer	2.9e-05	0.000103	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GGT1—liver cancer	2.9e-05	0.000103	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GOT2—liver cancer	2.87e-05	0.000102	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GSTP1—liver cancer	2.86e-05	0.000102	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CD—liver cancer	2.86e-05	0.000101	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—HMOX1—liver cancer	2.82e-05	0.0001	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—ALB—liver cancer	2.82e-05	0.0001	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—KDR—liver cancer	2.74e-05	9.73e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MAPK14—liver cancer	2.72e-05	9.67e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP2E1—liver cancer	2.7e-05	9.59e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—KDR—liver cancer	2.7e-05	9.58e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MAPK14—liver cancer	2.68e-05	9.51e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ESR1—liver cancer	2.67e-05	9.49e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3CB—liver cancer	2.67e-05	9.48e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—F2—liver cancer	2.64e-05	9.37e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GSTP1—liver cancer	2.63e-05	9.34e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ESR1—liver cancer	2.63e-05	9.33e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GSTM1—liver cancer	2.63e-05	9.33e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.62e-05	9.29e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GSTP1—liver cancer	2.61e-05	9.26e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—F2—liver cancer	2.6e-05	9.22e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—HMOX1—liver cancer	2.59e-05	9.21e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PIK3CB—liver cancer	2.59e-05	9.21e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CG—liver cancer	2.58e-05	9.17e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—HMOX1—liver cancer	2.57e-05	9.13e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYCS—liver cancer	2.53e-05	8.97e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—APC—liver cancer	2.53e-05	8.97e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CG—liver cancer	2.53e-05	8.97e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PPARG—liver cancer	2.49e-05	8.85e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CYP1A1—liver cancer	2.49e-05	8.84e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CB—liver cancer	2.49e-05	8.84e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—APC—liver cancer	2.49e-05	8.82e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CG—liver cancer	2.49e-05	8.82e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GGT1—liver cancer	2.48e-05	8.81e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GOT1—liver cancer	2.48e-05	8.81e-05	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PIK3CA—liver cancer	2.45e-05	8.71e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GSTM1—liver cancer	2.42e-05	8.58e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GSTM1—liver cancer	2.4e-05	8.51e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—BRAF—liver cancer	2.37e-05	8.43e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—BRAF—liver cancer	2.34e-05	8.29e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—MTHFR—liver cancer	2.32e-05	8.24e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CYP1A1—liver cancer	2.29e-05	8.13e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PPARA—liver cancer	2.28e-05	8.09e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CYP1A1—liver cancer	2.27e-05	8.06e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CD—liver cancer	2.27e-05	8.06e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—ALB—liver cancer	2.24e-05	7.96e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GSTP1—liver cancer	2.23e-05	7.91e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CD—liver cancer	2.22e-05	7.88e-05	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—PIK3CA—liver cancer	2.2e-05	7.81e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—HMOX1—liver cancer	2.2e-05	7.8e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SERPINE1—liver cancer	2.2e-05	7.8e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CD—liver cancer	2.19e-05	7.76e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—KRAS—liver cancer	2.17e-05	7.72e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—PIK3CA—liver cancer	2.16e-05	7.68e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SERPINE1—liver cancer	2.16e-05	7.67e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—KRAS—liver cancer	2.14e-05	7.59e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—MTHFR—liver cancer	2.14e-05	7.58e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—MTHFR—liver cancer	2.12e-05	7.52e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PPARA—liver cancer	2.1e-05	7.44e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PPARA—liver cancer	2.08e-05	7.38e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GSTM1—liver cancer	2.05e-05	7.27e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.05e-05	7.27e-05	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—AKT1—liver cancer	2e-05	7.11e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PIK3CA—liver cancer	2e-05	7.09e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—RAF1—liver cancer	1.98e-05	7.04e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CB—liver cancer	1.98e-05	7.02e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PIK3CA—liver cancer	1.97e-05	6.98e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CG—liver cancer	1.95e-05	6.93e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—RAF1—liver cancer	1.95e-05	6.92e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP1A1—liver cancer	1.94e-05	6.89e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CB—liver cancer	1.94e-05	6.87e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MTOR—liver cancer	1.94e-05	6.87e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MTOR—liver cancer	1.9e-05	6.76e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CB—liver cancer	1.9e-05	6.76e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PPARG—liver cancer	1.88e-05	6.69e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.87e-05	6.62e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—HRAS—liver cancer	1.85e-05	6.56e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—HRAS—liver cancer	1.82e-05	6.45e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CDKN1B—liver cancer	1.82e-05	6.45e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—MTHFR—liver cancer	1.81e-05	6.42e-05	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—AKT1—liver cancer	1.8e-05	6.38e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CG—liver cancer	1.79e-05	6.37e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CDKN1B—liver cancer	1.79e-05	6.34e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CASP3—liver cancer	1.78e-05	6.32e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CG—liver cancer	1.78e-05	6.32e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL2—liver cancer	1.78e-05	6.31e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PPARA—liver cancer	1.78e-05	6.3e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—IL6—liver cancer	1.77e-05	6.28e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—AKT1—liver cancer	1.77e-05	6.28e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CASP3—liver cancer	1.75e-05	6.22e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL2—liver cancer	1.75e-05	6.21e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—IL6—liver cancer	1.74e-05	6.18e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CCND1—liver cancer	1.73e-05	6.15e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PPARG—liver cancer	1.73e-05	6.15e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—JUN—liver cancer	1.73e-05	6.14e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PPARG—liver cancer	1.72e-05	6.1e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CTNNB1—liver cancer	1.72e-05	6.09e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CD—liver cancer	1.72e-05	6.09e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CCND1—liver cancer	1.71e-05	6.05e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—JUN—liver cancer	1.7e-05	6.04e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ALB—liver cancer	1.69e-05	6.01e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CTNNB1—liver cancer	1.69e-05	5.99e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MMP9—liver cancer	1.68e-05	5.97e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CDKN1A—liver cancer	1.68e-05	5.95e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MMP9—liver cancer	1.66e-05	5.88e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CDKN1A—liver cancer	1.65e-05	5.86e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MAPK8—liver cancer	1.64e-05	5.81e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—AKT1—liver cancer	1.63e-05	5.79e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3CA—liver cancer	1.63e-05	5.78e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MAPK8—liver cancer	1.61e-05	5.72e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—AKT1—liver cancer	1.61e-05	5.7e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.59e-05	5.66e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PIK3CA—liver cancer	1.58e-05	5.61e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CD—liver cancer	1.58e-05	5.6e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CD—liver cancer	1.56e-05	5.55e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ALB—liver cancer	1.56e-05	5.53e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ALB—liver cancer	1.54e-05	5.48e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CG—liver cancer	1.52e-05	5.4e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CA—liver cancer	1.52e-05	5.39e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—VEGFA—liver cancer	1.51e-05	5.36e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—STAT3—liver cancer	1.5e-05	5.31e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CB—liver cancer	1.5e-05	5.31e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—VEGFA—liver cancer	1.49e-05	5.28e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—STAT3—liver cancer	1.47e-05	5.22e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PPARG—liver cancer	1.47e-05	5.21e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MYC—liver cancer	1.39e-05	4.93e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TGFB1—liver cancer	1.39e-05	4.92e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CB—liver cancer	1.38e-05	4.88e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MYC—liver cancer	1.37e-05	4.86e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TGFB1—liver cancer	1.36e-05	4.84e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CB—liver cancer	1.36e-05	4.84e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CD—liver cancer	1.34e-05	4.74e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—AKT1—liver cancer	1.33e-05	4.72e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ALB—liver cancer	1.32e-05	4.68e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—AKT1—liver cancer	1.29e-05	4.58e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—KRAS—liver cancer	1.28e-05	4.56e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—KRAS—liver cancer	1.26e-05	4.49e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—AKT1—liver cancer	1.24e-05	4.4e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CA—liver cancer	1.21e-05	4.28e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CA—liver cancer	1.18e-05	4.19e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CB—liver cancer	1.17e-05	4.14e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CA—liver cancer	1.16e-05	4.12e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TP53—liver cancer	1.14e-05	4.05e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TP53—liver cancer	1.12e-05	3.99e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HRAS—liver cancer	1.09e-05	3.88e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HRAS—liver cancer	1.07e-05	3.81e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL6—liver cancer	1.04e-05	3.71e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL6—liver cancer	1.03e-05	3.65e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—AKT1—liver cancer	9.85e-06	3.5e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—AKT1—liver cancer	9.64e-06	3.42e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—AKT1—liver cancer	9.49e-06	3.37e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CA—liver cancer	9.12e-06	3.24e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CA—liver cancer	8.38e-06	2.98e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CA—liver cancer	8.31e-06	2.95e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—AKT1—liver cancer	7.45e-06	2.64e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CA—liver cancer	7.1e-06	2.52e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—AKT1—liver cancer	6.85e-06	2.43e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—AKT1—liver cancer	6.79e-06	2.41e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—AKT1—liver cancer	5.8e-06	2.06e-05	CbGpPWpGaD
